NCT07416188 2026-04-17
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Not yet recruiting
National Institutes of Health Clinical Center (CC)
IRCCS Ospedale San Raffaele
Mayo Clinic
University of Alabama at Birmingham
Nationwide Children's Hospital
Mayo Clinic
Yale University
Tetragon Biosciences Ltd